EF
TMO icon

Empowered Funds’s Thermo Fisher Scientific TMO Stock Holding History

Empowered Funds’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
36,395
+3,959
+12% +$1.9M 0.1% 218
2026
Q1 		$15.9M Buy
+32,436
New +$17.6M 0.1% 218
2025
Q4 		– Sell
-19,372
Closed -$9.4M – 1818
2025
Q3 		$9.4M Buy
19,372
+4,766
+33% +$2.22M 0.09% 246
2025
Q2 		$5.92M Buy
14,606
+3,213
+28% +$1.34M 0.07% 392
2025
Q1 		$5.67M Sell
11,393
-15
-0.1% -$8.12K 0.08% 343
2024
Q4 		$5.93M Buy
11,408
+1,720
+18% +$946K 0.09% 329
2024
Q3 		$5.99M Buy
9,688
+686
+8% +$406K 0.09% 305
2024
Q2 		$4.98M Buy
9,002
+1,298
+17% +$744K 0.09% 312
2024
Q1 		$4.48M Buy
7,704
+2,677
+53% +$1.5M 0.08% 342
2023
Q4 		$2.67M Buy
5,027
+966
+24% +$468K 0.07% 417
2023
Q3 		$2.06M Buy
4,061
+877
+28% +$467K 0.06% 441
2023
Q2 		$1.66M Buy
3,184
+1,480
+87% +$799K 0.06% 465
2023
Q1 		$982K Buy
+1,704
New +$960K 0.06% 296

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Empowered Funds's TMO Position: Q2 2026 in Review

Empowered Funds increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, buying an estimated $1.9M and bringing the position to 36,395 shares worth $18.2M. The position accounts for 0.1% of the portfolio, ranked #218.

Empowered Funds first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Empowered Funds held 36,395 shares of Thermo Fisher Scientific worth $18.2M as of Q2 2026.
  • Empowered Funds bought 3,959 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.9M.
  • Thermo Fisher Scientific made up 0.1% of Empowered Funds's portfolio in Q2 2026, its #218 holding.
  • Empowered Funds first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.